[Edaily Reporter Shin Ha-yeon ] NAMU TECH CO.,LTD.(242040)announced on the 13th that it will transition from a structure led solely by CEO Jeong Cheol to a co-CEO structure led by Jeong Cheol and Kim Hwa-joong in order to improve operational efficiency.
Disclosure Plus
NAMU TECH CO.,LTD. Transitions to a Co-CEO System Led by Jeong Cheol and Kim Hwa-joong
Shin Ha-yeon
2026-07-13 14:56:52
Economy
Corporation
IT·Science
Economy
NEXTBIOMEDICAL CO., LTD., Which Made Its Mark Globally with NexPowder, Named a “KOSDAQ Rising Star” for the Second Consecutive Year
#NEXTBIOMEDICAL CO., LTD., a company specializing in innovative medical devices, has been named to the Korea Exchange’s “KOSDAQ Rising Star” list for the second consecutive year, once again demonstrat…
Corporation
Celltrion, Buoyed by Direct Sales, Expands into Asia’s Pharm-Emerging Markets... Solidifies No. 1 Position and Prepares New Drugs
Celltrion(068270)Celltrion is strengthening its market dominance in Asia—a leading “Shinhung” (emerging pharmaceutical) market—by leveraging its unrivaled direct-to-market competitiveness. While its f…
IT·Science
LGCHEM,LTD Begins Preclinical Trials for ‘GNV205,’ an Immunotherapy Drug Based on Genube Technology
#
LGCHEM,LTD is set to begin preclinical research on “GNV205,” an antibody-cytokine fusion candidate acquired from the domestic biotech firm GenuV. The company plans to develop it as a next-gen…
